These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33992378)
21. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel. Uner M; Wissing SA; Yener G; Müller RH Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122 [TBL] [Abstract][Full Text] [Related]
22. The role of nanostructured lipid carriers and type of biopolymers on the lipid digestion and release rate of curcumin from curcumin-loaded oleogels. Zhang J; Chuesiang P; Kim JT; Shin GH Food Chem; 2022 Oct; 392():133306. PubMed ID: 35636193 [TBL] [Abstract][Full Text] [Related]
23. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770 [TBL] [Abstract][Full Text] [Related]
24. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide? Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838 [TBL] [Abstract][Full Text] [Related]
26. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Doktorovova S; Souto EB; Silva AM Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267 [TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033 [TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Uner M Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531 [TBL] [Abstract][Full Text] [Related]
29. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. Aditya NP; Shim M; Lee I; Lee Y; Im MH; Ko S J Agric Food Chem; 2013 Feb; 61(8):1878-83. PubMed ID: 23362941 [TBL] [Abstract][Full Text] [Related]
30. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR; Hua SC; Yang YL; Fang JY Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [TBL] [Abstract][Full Text] [Related]
32. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
34. β-carotene and α-tocopherol coencapsulated in nanostructured lipid carriers of murumuru ( Gomes GVL; Sola MR; Rochetti AL; Fukumasu H; Vicente AA; Pinho SC J Microencapsul; 2019 Jan; 36(1):43-52. PubMed ID: 30836027 [TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
36. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
37. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability. Talegaonkar S; Bhattacharyya A AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893 [TBL] [Abstract][Full Text] [Related]
38. Development of lycopene-loaded nanostructured lipid carriers: effect of rice oil and cholesterol. Riangjanapatee P; Müller RH; Keck CM; Okonogi S Pharmazie; 2013 Sep; 68(9):723-31. PubMed ID: 24147340 [TBL] [Abstract][Full Text] [Related]
39. Development and Evaluation of Lipid Nanoparticles for Drug Delivery: Study of Toxicity In, Vitro and In Vivo. Winter E; Dal Pizzol C; Locatelli C; Crezkynski-Pasa TB J Nanosci Nanotechnol; 2016 Feb; 16(2):1321-30. PubMed ID: 27433582 [TBL] [Abstract][Full Text] [Related]
40. Can lipid nanoparticles improve intestinal absorption? Mendes M; Soares HT; Arnaut LG; Sousa JJ; Pais AACC; Vitorino C Int J Pharm; 2016 Dec; 515(1-2):69-83. PubMed ID: 27667757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]